Rami Komrokji: Combining GenoMed and Moffitt database
Rami Komrokji, Vice chair of the Malignant Hematology Department and the head of the Leukemia and MDS Section at the Moffitt Cancer Center, shared a post on X:
“Honored to be co-senior author on this effort led by Dr Della Porta combining GenoMed and Moffitt database. Moffitt Cancer Center Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of AHSCT in Patients With MDS | Journal of Clinical Oncology.”
Amer Zeidan, Medical Director of Hematology Early Therapeutics Research, shared their research, adding:
“Excellent international collaboration led by GenoMed4All. Dr. Della Porta on using IPSS-M Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes MDSsm | Journal of Clinical Oncology.”
Read further.
Source: Rami Komrokji/X and Amer Zeidan/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023